small molecule

ULTRATAG

TECHNETIUM TC-99M RED BLOOD CELL KIT

Loss of exclusivity—loss of exclusivity

CompanyCurium Pharma →See this company's full patent-cliff portfolio

Drug detail

Brand name	ULTRATAG
Active ingredient	TECHNETIUM TC-99M RED BLOOD CELL KIT
Strength	N/A
Dosage form	INJECTABLE
Route	INJECTION
Modality	Small molecule
FDA approval	June 1991
Marketing status	RX

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.